{"id":"W3032084356","doi":"10.1177/1753466620926949","title":"Early and sustained symptom improvement with umeclidinium/vilanterol <i>versus</i> monotherapy in COPD: a <i>post hoc</i> analysis of the EMAX randomised controlled trial","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"GlaxoSmithKline","keywords":"Medicine; Post-hoc analysis; COPD; Randomized controlled trial; Post hoc; Internal medicine; Physical therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006460055,0.002407207,0.005899897,0.0005360803,0.0003861004,0.001574355,0.001250899,0.001838197,0.005785634],"category_scores_gemma":[0.005195965,0.000826469,0.005563817,0.0004687289,0.001544029,0.001787646,0.0007929154,0.00319585,0.0007775245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001019311,"about_ca_system_score_gemma":0.001121534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006077112,"about_ca_topic_score_gemma":0.00104484,"domain_scores_codex":[0.9959159,0.002832701,0.0002655396,0.0004271716,0.0001786728,0.0003799245],"domain_scores_gemma":[0.9956727,0.002025187,0.001082277,0.0004126707,0.0002559417,0.0005512674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9949892,0.0007768439,0.0001339221,0.0002928521,0.0007761123,0.0000116706,0.00001590416,0.00009796211,0.0008268435,0.00003147877,0.0001029502,0.001944316],"study_design_scores_gemma":[0.9257949,0.06928172,0.001529658,0.0000462857,0.001833103,0.00001776776,0.00002405701,0.0004288747,0.0006296409,0.0001158384,0.000274124,0.00002403319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984705,0.005335332,0.001180399,0.0007102852,0.0007560084,0.00440077,0.0009704406,0.0001504204,0.001791477],"genre_scores_gemma":[0.9862192,0.001793994,0.002227588,0.0006050371,0.0007092932,0.004841564,0.0007601236,0.00005059578,0.002792573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006460055,"threshold_uncertainty_score":0.03416443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01608565026385181,"score_gpt":0.2997480114759901,"score_spread":0.2836623612121383,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}